Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

REMEVi vs Vitalex Health

REMEVi
Graded #105

Higher grade

vs+10.700000000000003
Vitalex Health
Graded #338

Lower grade

The verdict

REMEVi takes it — 70.4/100 to 59.7/100.

REMEVi grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. REMEVi is the first bilingual (English and Spanish) GLP-1 telehealth clinic — care delivered by clinicians trained in both languages, never auto-translated.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
54
54
Dose & formulationEven
64
64
Clinical oversightREMEVi +22
86
64
Labs & monitoringREMEVi +13
65
52
FulfillmentREMEVi +27
97
70
Contract termsREMEVi +14
69
55
REMEVi · left barVitalex Health · right bar

The numbers

MetricREMEViVitalex Health
WeighScore70.4/10059.7/100
GradeCC
Scorecard rank#105#338
Semaglutide$199/mo (starting dose, compounded)$199/mo (starting dose, compounded)
Tirzepatide$269/mo (starting dose, compounded)$199/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
REMEVi

Graded #105 · C

Strengths

  • The first bilingual GLP-1 clinic — care delivered in English and Spanish by clinicians trained in both, not auto-translated
  • Compounded semaglutide from $199/mo and tirzepatide from $269/mo on the 52-week plan, with the same price every month (no titration price hikes)
  • LegitScript-certified and licensed in all 50 states + DC, with an NPI-verified pharmacy and overnight shipping
  • Transparent all-inclusive pricing with no hidden fees and cancel anytime; full legal suite (Privacy, Terms, HIPAA, Refund)

Where it loses points

  • Lowest pricing requires a 52-week commitment — month-to-month is higher ($279 semaglutide / $339 tirzepatide)
  • Compounded medications are not FDA-approved (the site discloses this) — not brand Wegovy or Zepbound
  • The specific compounding pharmacy is not named (described as 'NPI-verified')
  • A newer, patient-founded clinic; press mentions (Fortune, AP, Reuters) are syndicated PR, not editorial endorsements
Vitalex Health

Graded #338 · C

Strengths

  • Flat-rate pricing starting at $199/mo with no consultation fee or dose-change surcharges
  • Three distinct programs — Semaglutide, Tirzepatide, and a lower-dose GLP-1 Microdose protocol for body composition
  • Names its legal entity (Vitalex Health, LLC), a real street address, phone number, and posted clinical hours
  • Named lead clinician (Laqueta Nelson, MSN, FNP-BC) instead of an anonymous care team
  • Working Terms of Service, Privacy Policy, and HIPAA Notice pages, not dead links

Where it loses points

  • Brands itself “physician-led” sitewide, but the only named clinician is a nurse practitioner (FNP-BC), not a physician
  • No LegitScript seal or other third-party pharmacy-verification badge found anywhere on the site
  • Compounding pharmacy and prescribing medical group are referenced only generically — neither is named
  • Exact price is not published — the $199/mo figure is only a starting point confirmed after provider review
  • Domain was registered in April 2026 — a brand-new practice with no independent reviews found

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard